Regions Financial Corp. announced the company will present at the RBC Capital Markets Global Financial Institutions Conference on March 5.

Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins "Squawk Box' to discuss the latest market trends, ...

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...

RBC Capital analyst Paul Treiber maintained a Buy rating on Celestica (CLS – Research Report) today and set a price target of $160.00. The ...

Fintel reports that on February 4, 2025, RBC Capital downgraded their outlook for Olin (NYSE:OLN) from Outperform to Sector ...

Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...

FMC (NYSE:FMC) on Wednesday was downgraded to Underperform from a previous investment rating of Neutral by analysts at Bank ...

Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...

Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...

Want to learn more about the future of family offices as it unfolds in 2025? Read this article to explore key predictions for ...

Canadian stocks rose Tuesday after an agreement between Prime Minister Justin Trudeau’s government and the White House to ...

RBC Capital Markets also maintained a cautious view on Ford and the overall U.S. automotive sector, but still expects slightly above consensus thanks to stronger retail sales for Q4. For 2025, it ...